Press Releases

NASDAQ
SPPI
$10.43
--0.10
DAY HI:
$10.64
DAY LOW:
$10.37
VOLUME:
1,076,042
4:00 PM EST 01/23/19

Press Releases

Date Title View PDF
Dec 2, 2016 Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 3-6, 2016
Nov 17, 2016 Spectrum Pharmaceuticals Announces Poziotinib Data Presentation at the 17th IASLC World Conference on Lung Cancer in Vienna, Austria, December 4-7, 2016
Nov 14, 2016 Spectrum Pharmaceuticals Provides Third Quarter Financial Update
Nov 3, 2016 Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update
Oct 27, 2016 Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference and Webcast
Oct 18, 2016 Spectrum Pharmaceuticals Announces Appointment of Luigi Lenaz, M.D., as Lead Director
Sep 14, 2016 FDA Advisory Committee Votes that Qapzola™ (apaziquone) Has Not Shown Substantial Evidence of a Treatment Effect Over Placebo
Aug 9, 2016 Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update
Aug 2, 2016 Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference and Webcast
Jul 13, 2016 Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation
Jul 6, 2016 Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald's 2nd Annual Healthcare Conference on July 13th
Jun 1, 2016 Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th
May 6, 2016 Spectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of the American Urological Association Education and Research Inc. (AUA) in San Diego, California, May 6-10, 2016
May 5, 2016 Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update
May 3, 2016 Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2016 Healthcare Conference on May 10th
Apr 28, 2016 Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast
Apr 20, 2016 FDA Grants Orphan Drug Exclusivity to EVOMELA™ (melphalan) for Injection, Indicated for Multiple Myeloma
Mar 15, 2016 FDA Grants Spectrum Pharmaceuticals Approval of EVOMELA™ (melphalan) for Injection
Mar 9, 2016 Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update
Mar 7, 2016 Spectrum Pharmaceuticals Initiates Phase 2 Breast Cancer Trial for Poziotinib, a Novel Pan-HER Inhibitor
Mar 2, 2016 Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results Teleconference and Webcast
Feb 22, 2016 Spectrum Pharmaceuticals to Present Corporate Update at 2016 RBC Capital Markets' Global Healthcare Conference on February 24
Feb 19, 2016 Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for EOquin® (apaziquone for intravesical instillation)
Jan 29, 2016 Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer
Jan 11, 2016 Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada
Displaying records 76 - 100 of 766